In hepatocellular carcinoma, MYC binds to PD-L1 and increases its expression, promoting an immunosuppressive TME, and inactivating MYC reduces PD-L1 expression, which enhances the antitumor response [114]. Here, CD274 is linked to hepatocellular carcinoma.